MedTrace Logo

Pedometer and Exercise Study in Prostate Cancer Patients With Hormonal Therapy

NCT00868868 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2009-03-25

No results posted yet for this study

Summary

A randomized clinical trial evaluating the use of a pedometer and brief exercise coaching in prostate cancer patients treated with androgen deprivation therapy. The investigators want to demonstrate if there are less side effects of hormonal therapy and better quality of life in patients who made regular exercise.

Conditions

Sponsors & Collaborators

  • Groupe de recherche en Urologie de la Mauricie

    lead OTHER

Principal Investigators

  • Dr Alain Maillette, urologist · Groupe de recherche en Urologie de la Mauricie

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2011-09-30
Completion
2011-09-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00868868 on ClinicalTrials.gov